If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements


       •  19 Feb 2018: Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Subunit Vaccines


 • 5 Mar 2018: Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America

• 15 Mar 2018: R&D Portfolio Update March 2018: DNDi Sleeping sickness programme

• 15 Mar 2018: R&D Portfolio Update March 2018: DNDi Leishmaniasis programme

• 15 Mar 2018: R&D Portfolio Update March 2018: DNDi Chagas disease programme

• 15 Mar 2018: R&D Portfolio Update March 2018: DNDi Filarial diseases programme

• 15 Mar 2018: R&D Portfolio Update March 2018: DNDi Mycetoma programme


     •  1 Feb 2018: Agenda for action: Diagnostics central to tackling rising AMR burden across Africa

     •  26 Feb 2018: FIND launches digital connectivity service for the global health community, powered by TELECOM26 AG



     •  6 Mar 2018: Interim Results of Open-Label Study of IPM’s Dapivirine Vaginal Ring Find Increased Product Use and Suggest Greater HIV Risk Reduction


     •  14 Feb 2018: MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF


     •  1 Feb 2018: LabCorp CEO Dave King becomes PATH board chair

     •  5 Feb 2018: Tackling a silent killer: information and testing for hepatitis C becomes more available in Ho Chi Minh City thanks to integration into community-led services

     •  6 Feb 2018: Cara Bradley named Chief Corporate Engagement Officer for PATH; Kathryn Kennedy joins as Head of Media

     •  7 Feb 2018: First vaccine carrier approved by World Health Organization to prevent vaccine freezing during transport commercially available

•  12 Feb 2018: PATH statement on the US Administration’s proposed Fiscal Year 2019 budget

TB Alliance

 •  6 Mar 2018: Nancy Miller-Rich Joins TB Alliance Board of Directors


PDP Funder Announcements

Wellcome Trust

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements


New PDP Publications

•  Feb 2018: Maximizing the Health Impact of Diagnostic Solutions: Access Strategy 2018. FIND

Other Reports/ Publications

•  Feb 2018: One year on, Global Observatory on Health R&D identifies striking gaps and inequalities. WHO

Related Press Releases/ Announcements/ non-Peer Reviewed Articles

•  1 Mar: Innovative 'invisible ink' detects TB. Science Daily

•  1 Mar: Remembering Albert Sabin and the vaccine that changed the world. STAT

•  2 Mar: HIV begins to yield secrets of how it hides in cells. MedicalXpress

•  2 Mar: Hope for Hepatitis C patients. The Star Online

•  2 Mar: WHO Joint Tropical Disease Program Issues Report On Research Fairness. IP Watch

•  3 Mar: Pharmaceutical corporations need to stop free-riding on publicly-funded research. The Hill

•  5 Mar: Lassa fever: The killer disease with no vaccine. BBC

•  5 Mar: Vaccines: Reflecting on 2017 and what’s on the 2018 horizon. IFPMA

•  5 Mar: Test spots malaria in two minutes, without blood. SciDevNet

•  6 Mar: Seventeen people volunteer to have potentially deadly parasitic worms injected into their bodies as part of search for vaccine. The Independent

•  6 Mar: Global health coalition inks agreement to develop vaccines for MERS, Lassa fever. STAT News

•  6 Mar: Fast-Acting Tuberculosis Prophylaxis in the Works. Medscape

•  7 Mar: CROI 2018: Women controlled HIV-protection gains ground with interim results from open-label trials of antiretroviral vaginal ring. Science Speaks

•  7 Mar: Malaria-free but still sick: What’s giving millions of kids fevers?. Science

•  7 Mar: HIV vaccine in the works, but hard to predict timeline: Mark Feinberg. Business Standard

•  8 Mar: Getting gender into your science means more than “add women and stir. Science Speaks

•  8 Mar: Gene knockout using new CRISPR tool makes mosquitoes highly resistant to malaria parasite. Science Daily

•  8 Mar: Diagnostic lab group in India to offer HCV and HIV tests at almost half the price. Indian Express

•  8 Mar: WHO launches plan for cheaper TB drugs. The Hindu

•  8 Mar: Dapivirine Ring Shown to Reduce HIV-Risk in Women by 54%. Contagion Live

•  9 Mar: CRISPR use creates Malaria-Resistant mosquitoes. Genetic Engineering and Biotechnology News

•  8 Feb: New campaign seeks to reignite political support for the fight against malaria. Devex

•  12 Feb: Blue dye blocks malaria transmission. Healio

•  12 Feb: SK, Sanofi strike $155-mil licensing agreement for vaccine tech. Korea Biomedical Review

•  13 Feb: China's growing innovation capacity to play bigger role in global health: Bill Gates. Xinhua Net

•  13 Mar: India to create new essential list to improve access to life-saving diagnostic tests. The Economic Times of India

•  13 Feb: Can gene therapy be harnessed to fight AIDS?. STAT News

•  14 Feb: Findings indicate two newest TB drugs, bedaquiline and delamanid in combination safe, promising for patients with few options. Science Speaks

•  14 Feb: Novartis forms alliance to develop medicines for treating infectious diarrheal disease. Nasdaq Global Newswire

•  14 Feb: Novartis gets $6.5m from Gates Foundation for diarrhoea drug. Pharma Times

•  14 Feb: Do We Need A Global Body To Set Priorities For Diseases And Research?. IP Watch

•  14 Feb: Fewer Scientists Are Studying Insects. Here’s Why That’s So Dangerous. Time

•  14 Feb: Innovations For All: Swiss-Led Panel Looks At What Works, What Doesn’t. IP Watch

•  15 Mar: India aims to eliminate TB by 2025. Devex

•  15 Feb: New CRISPR tools can detect infections like HPV, dengue, and Zika. The Verge

•  16 Mar: Exclusive: AIDS researcher favoured to be next CDC chief. Politico

•  19 Feb: Opinion: The global development community asks tough questions. Here are the answers. Devex

•  20 Feb: Understanding how research can better engage aid policy. Devex

•  20 Feb: Tracking dormant malaria: Novel technology could allow researchers to develop and test new antimalaria drugs. Science Daily

•  21 Feb: How to accelerate pharmaceutical R&D: A new framework for sharing IP with global health researchers. Access to Medicines Foundation

•  23 Feb: Drug trial eyed for one of the leading causes of child mortality. Devex

•  23 Feb: Modifications in HIV test enable rapid detection of Zika virus, study states. Medical News Life Sciences

•  28 Feb: In the year of TB, advocates want more than a political commitment. Devex

•  28 Feb: Novo to invest $165m in first ‘superbug’ venture fund. Financial Times


Articles/ Reports on PDP related issues (peer reviewed) 

•  The dengue vaccine dilemma.  The Lancet Infectious Diseases, DOI: https://doi.org/10.1016/S1473-3099(18)30023-9, Feb 2018.

•  Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. G Ferlazzo, et al., Lancet Infectious Diseases, DOI: https://doi.org/10.1016/S1473-3099(18)30100-2, Feb 13, 2018.

Upcoming Meetings/  Webinars

April 15 - 20, 2018

MIM Pan African Malaria Conference 2018

Dakar, Senegal